Literature DB >> 21328460

miR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion.

Jun Zheng1, Hui Xue, Tao Wang, Yuegui Jiang, Bei Liu, Jianhu Li, Yanpu Liu, Wei Wang, Bin Zhang, Moyi Sun.   

Abstract

The present study was undertaken to investigate the regulation of P12(CDK2AP1) by miRNAs. A conserved target site for miR-21 within the CDK2AP1-3'-UTR at nt 349-370 was predicted by bioinformatics software and an inverse correlation of miR-21 and CDK2AP1 protein was observed. Highly specific amplification and quantification of miR-21 was achieved using real-time RT-PCR. Transfection of HaCaT cells with pre-miR-21 significantly suppressed a luciferase reporter including the CDK2AP1-3'-UTR, whereas transfection of Tca8113 with anti-miR-21 increased activity of this reporter. This was abolished when a construct mutated at the miR-21/nt 349-370 target site was used instead. Anti-miR-21-transfected Tca8113 cells showed an increase of CDK2AP1 protein and reduced proliferation and invasion. Resected primary tumors and tumor-free surgical margins of 18 patients with head and neck squamous cell carcinomas demonstrated an inverse correlation between miR-21 and P12(CDK2AP1). This study shows that P12(CDK2AP1) is downregulated by miR-21 and that miR-21 promotes proliferation and invasion in cultured cells.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21328460     DOI: 10.1002/jcb.22995

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  29 in total

Review 1.  From microRNAs to targets: pathway discovery in cell fate transitions.

Authors:  Deepa Subramanyam; Robert Blelloch
Journal:  Curr Opin Genet Dev       Date:  2011-06-01       Impact factor: 5.578

2.  MicroRNA-21 promotes oral cancer invasion via the Wnt/β-catenin pathway by targeting DKK2.

Authors:  Akiko Kawakita; Souichi Yanamoto; Shin-Ichi Yamada; Tomofumi Naruse; Hidenori Takahashi; Goro Kawasaki; Masahiro Umeda
Journal:  Pathol Oncol Res       Date:  2013-09-03       Impact factor: 3.201

3.  MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility.

Authors:  Liang Zhu; Huarong Chen; Donger Zhou; Dan Li; Rui Bai; Shu Zheng; Weiting Ge
Journal:  Med Oncol       Date:  2011-05-12       Impact factor: 3.064

4.  Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer.

Authors:  Ting Zhang; Ping Zou; Tiejun Wang; Jingying Xiang; Jing Cheng; Daozhen Chen; Jianwei Zhou
Journal:  Tumour Biol       Date:  2016-01-11

Review 5.  Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation.

Authors:  D T W Wong; J J Kim; O Khalid; H H Sun; Y Kim
Journal:  J Dent Res       Date:  2011-08-24       Impact factor: 6.116

6.  miRNA-21 ablation protects against liver injury and necroptosis in cholestasis.

Authors:  Marta B Afonso; Pedro M Rodrigues; André L Simão; Maria M Gaspar; Tânia Carvalho; Paula Borralho; Jesús M Bañales; Rui E Castro; Cecília M P Rodrigues
Journal:  Cell Death Differ       Date:  2017-12-11       Impact factor: 15.828

Review 7.  Regulation of cancer metastasis by cell-free miRNAs.

Authors:  Maša Alečković; Yibin Kang
Journal:  Biochim Biophys Acta       Date:  2014-10-28

Review 8.  Regulation and function of miRNA-21 in health and disease.

Authors:  Regalla Kumarswamy; Ingo Volkmann; Thomas Thum
Journal:  RNA Biol       Date:  2011-07-07       Impact factor: 4.652

9.  Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach.

Authors:  R Nedaeinia; M Sharifi; A Avan; M Kazemi; L Rafiee; M Ghayour-Mobarhan; R Salehi
Journal:  Cancer Gene Ther       Date:  2016-07-01       Impact factor: 5.987

10.  mRNA Expression of CDK2AP1 in Human Breast Cancer: Correlation with Clinical and Pathological Parameters.

Authors:  Ritika Gera; Leon Mokbel; Wen G Jiang; Kefah Mokbel
Journal:  Cancer Genomics Proteomics       Date:  2018 Nov-Dec       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.